节点文献

Study on Drug Property Differences of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum) Based on Analysis of Biothermodynamics

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 程丹红王建曾南夏厚林傅勇鄢丹赵艳玲肖小河

【Author】 CHENG Dan-hong 1,2, WANG Jian 1, ZENG Nan1, XIA Hou-lin 1, FU Yong 1, YAN Dan 2, ZHAOYan-ling 2, and XIAO Xiao-he 21. Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610015, China; 2. China Military Institute of Chinese Materia Medica, 302 Military Hospital of China, Beijing 100039, China

【机构】 Chengdu University of Traditional Chinese MedicineChina Military Institute of Chinese Materia Medica, 302 Military Hospital of China

【摘要】 Objective: To study the drug property differences of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum) with biothermodynamics, and to verify the objectivity and authenticity of the drug property. Methods: The growth-thermogram curves of Escherichia coli (E. coli) affected by Shexiang (Moschus) and Bingpian (Borneolum Synthcticum) at different concentrations were determined with microcalorimetry, and the power-time curves (thermogram curves) of E. coli metabolism and characteristic parameters, such as growth rate constant (k), maximum output power (Pm), peak time (tp), total heat-output (Qt), etc. were analyzed with the principal component analysis (PCA) to find the close correlative parameters, so as to objectively reflect the drug property differences of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum). Results: The values of P2 in the second exponential growth phase increased with the increase of the concentrations of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum), and the P2 of Shexiang (Moschus) was larger than that of Bingpian (Borneolum Synthcticum); Q2 increased with the increase of the concentrations of Shexiang (Moschus), but for Bingpian (Borneolum Synthcticum) it was opposite. It is indicated that they have different effects on P2 and Q2 of E. coli in the second exponential growth phase, and have differences in warm and cold natures. Conclusion: The microcalorimetry can accurately and objectively appraise differences of the drug property of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum) and verify the objectivity and authenticity of the drug property, so as to provide a new and useful method for studies of the drug property of Chinese drugs.

【Abstract】 Objective: To study the drug property differences of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum) with biothermodynamics, and to verify the objectivity and authenticity of the drug property. Methods: The growth-thermogram curves of Escherichia coli (E. coli) affected by Shexiang (Moschus) and Bingpian (Borneolum Synthcticum) at different concentrations were determined with microcalorimetry, and the power-time curves (thermogram curves) of E. coli metabolism and characteristic parameters, such as growth rate constant (k), maximum output power (Pm), peak time (tp), total heat-output (Qt), etc. were analyzed with the principal component analysis (PCA) to find the close correlative parameters, so as to objectively reflect the drug property differences of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum). Results: The values of P2 in the second exponential growth phase increased with the increase of the concentrations of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum), and the P2 of Shexiang (Moschus) was larger than that of Bingpian (Borneolum Synthcticum); Q2 increased with the increase of the concentrations of Shexiang (Moschus), but for Bingpian (Borneolum Synthcticum) it was opposite. It is indicated that they have different effects on P2 and Q2 of E. coli in the second exponential growth phase, and have differences in warm and cold natures. Conclusion: The microcalorimetry can accurately and objectively appraise differences of the drug property of Shexiang (Moschus) and Bingpian (Borneolum Synthcticum) and verify the objectivity and authenticity of the drug property, so as to provide a new and useful method for studies of the drug property of Chinese drugs.

【基金】 supported by National Key Basic Research and Development Plant (973),China (No. 2007CB512 606)
  • 【文献出处】 Journal of Traditional Chinese Medicine ,中医杂志(英文版) , 编辑部邮箱 ,2011年01期
  • 【分类号】R285
  • 【被引频次】1
  • 【下载频次】175
节点文献中: 

本文链接的文献网络图示:

本文的引文网络